Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04087902 · ClinicalTrials.gov registry record
Long-Term Longitudinal QoL in Patients Undergoing EEA
A clinical trial of Meningioma and Chordoma, sponsored by Ohio State University.
- Recruiting
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT04087902: Recruiting study of Meningioma and Chordoma, sponsored by Ohio State University.
NCT04087902 is a study of Meningioma and Chordoma that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 400 participants, above the 80-participant average among 21 other Meningioma trials with a reported enrollment target (400% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04087902, a study of Meningioma and Chordoma, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective longitudinal study to access postoperative 2-year quality of life in patients who undergo endonasal endoscopic approach surgeries of the skull base.
Primary Outcome
This study aims to better understand the long-term overall quality of life of patients undergoing endoscopic endonasal surgery using modern sinonasal reconstruction techniques. The PROMIS-29 metric, an overall quality of life metric, will be used to better understand quality of life for patients undergoing this procedure.
Conditions Studied
Study Locations (1)
Ohio
- Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2019-07-16 |
| Est. Completion | 2025-12-31 |
What NCT04087902 shows while recruiting
NCT04087902 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 80-participant average among 21 other Meningioma trials with a reported enrollment target (400% higher).
The record links to 8 conditions, with Meningioma appearing as the primary indexed condition, and to 0 interventions.
NCT04087902 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04087902 about?
NCT04087902 is a clinical study titled "Long-Term Longitudinal QoL in Patients Undergoing EEA". This is a prospective longitudinal study to access postoperative 2-year quality of life in patients who undergo endonasal endoscopic approach surgeries of the skull base.
What is the current status of trial NCT04087902?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2019-07-16. Estimated completion is 2025-12-31.
What conditions does trial NCT04087902 study?
This clinical trial studies the following conditions: Meningioma, Chordoma, Chondrosarcoma, Craniopharyngioma, Pituitary Tumor.
Who is sponsoring clinical trial NCT04087902?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04087902 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Meningioma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04087902's enrollment target sits among peer trials
400 1st of 21 higher than 21 of 21 other Meningioma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Meningioma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Abemaciclib in Newly Diagnosed Meningioma Patients
RECRUITING · Phase 2
-
Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
RECRUITING · Phase 1
-
Evaluation of the CONVIVO System
RECRUITING · NA
-
Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
RECRUITING
-
Cabozantinib for Patients With Recurrent or Progressive Meningioma
RECRUITING · Phase 2
-
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI